Clinical features of gastrointestinal tractus damage in patients with ankylosing spondylitis


DOI: https://dx.doi.org/10.18565/therapy.2019.1.119-124

Belousova E.N., Protopopov M.S., Abdulganieva D.I.

1 Department of hospital therapy of «Kazan state medical university» FSBEI of HE of the Ministry of Healthcare of Russia; 2 Charité Universitätsmedizin, Berlin (University clinic Charite, Berlin, FRG)
It is known that patients with inflammatory bowel disease (IBD) and ankylosing spondylitis (AS) have common pathogenetic features. As in patients with AS such disease as IBD can be developed, and in patients with IBD such disease as spondyloarthritis can developed also. In current study the description of the symptoms of gastrointestinal tractus damage in AS patients and a comparison of patients with AS vs patients with IBD and AS for demographic and clinical and laboratory indexes is introduced.
Keywords: Crohn’s disease, inflammatory bowel diseases, ankylosing spondylitis, ulcerative colitis
Read entire article

Literature


  1. Sieper J., Poddubnyy D. Axial spondyloarthritis. The Lancet. 2017; 390(10089): 73–84.

  2. Эрдес Ш.Ф., Бадокин В.В., Бочкова А.Г., Бугрова О.В., Гайдукова И.З., Годзенко А.А., Дубиков А.А., Дубинина Т.В.,Иванова О.Н., Коротаева Т.В., Лапшина С.А., Несмеянова О.Б., Никишина И.П., Оттева Э.Н., Раскина Т.А., Ребров А.П., Румянцева О.А., Ситало А.В., Смирнов А.В. О терминологии спондилоартритов. Научно-практическая ревматология. 2015; 53(6): 657–660.

  3. Насонов Е.Л. Ревматология: Клинические рекомендации, 2-е изд. Москва: ГЭОТАР-Медиа; 2010. 752 с.

  4. De Keyser F., Elewaut D., De Vos M., De Vlam K., Cuvelier C., Mielants H., Veys E. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am. 1998; 24(4): 785–813.

  5. Leirisalo-Repo M., Turunen U., Stenman S., Helenius P., Seppälä K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 1994; 37(1): 23–31.

  6. Salvarani C., Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009; 15(20): 2449–55.

  7. De Vos M., Mielants H., Cuvelier C., Elewaut A., Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology. 1996; 110(6):1696–1703.

  8. Van Praet L., Van den Bosch F., Jacques P. Carron P., Jans L., Colman R, Glorieus E., Peeters H., Mielants H., de Vos M., Cuvelier C., Elewaut D. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Annals of the rheumatic diseases. 2012; 72(3): 414–17.

  9. Van Praet L., Jans L., Carron P., Jacques P., Glorieus E., Colman R., Cypers H., Mielants H., de Vos M., Cuvelier C., van den Bosch F., Elewaut D. Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Annals of the rheumatic diseases. 2013; 73(6): 1186–89.

  10. Cypers H., Varkas G., Beeckman S., Debusschere K., Vogl T., Roth J., Drennan M.B., Lavric M., Foell D., Cuvelier C.A., de Vos M., Delanghe J., van den Bosch F., Elewaut D. (2015). Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Annals of the rheumatic diseases. 2015; 75(7): 1357–62.

  11. Van Praet L., Jacques P., Van den Bosch F., Elewaut, D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nature reviews rheumatology. 2012; 8(5): 288–95.

  12. Stebbings S., Jenks K., Treharne G., García J., Schultz M., Highton J., & Dudley-Brown S. (2011). Validation of the Dudley inflammatory bowel symptom questionnaire for the assessment of bowel symptoms in axial SpA: prevalence of clinically relevant bowel symptoms and association with disease activity. Rheumatology. 2011. 51(5): 858–65.

  13. Rizzello F., Olivieri I., Armuzzi A., Ayala F., Bettoli V., Bianchi L., Cimino L., Costanzo A., Cristaudo A., d’Angelo S., Daperno M., Fostini A., Galeazzi M., Gilio M., Gionchetti P., Gisondi P., Lubrano E., Marchesoni A., Offidani A., Orlando A., Pugliese D., Savarini C., Scarpa R., Vecchi M., Girolomoni G. Multidisciplinary management of spondyloarthritis-related immune-mediated inflammatory disease. Advances in therapy. 2018; 35(4): 545–62.

  14. Vavricka S., Schoepfer A., Scharl M., Lakatos P., Navarini A., Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflammatory bowel diseases. 2015; 21(8): 1982–92.

  15. Harbord M., Annese V., Vavricka S., Allez M., Barreiro-de Acosta M., Boberg K. et al. The First European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. Journal Of Crohn’s And Colitis. 2015; 10(3): 239–54.


About the Autors

Elena N. Belousova, assistant professor of the Department of hospital therapy of «Kazan state medical university» FSBEI of HE. Address: 420012, Republic of Tatarstan, Kazan, 49 Butlerova St. E-mail: vanilla16@mail.ru 
Mikhail S. Protopopov, PhD, research scientist of University clinic Charité. Address: 12203, Berlin, 30 Hindenburgdamm St. Tel.: +4930450514582. E-mail: mikhailprotopopov@gmail.com 
Diana I. Abdulganieva, MD, professor, head of the Department of hospital therapy of «Kazan state medical university» FSBEI of HE. Address: 420012, Republic of Tatarstan, Kazan, 49 Butlerova St. Tel.: +78432373483. E-mail: diana_s@mail.ru


Similar Articles

Back to Content

Бионика Медиа